Compugen (CGEN) EBIAT (2009 - 2026)

Compugen has disclosed EBIAT across 18 years of filings, most recently posting $7.7 million for Q1 2026.

• EBIAT for Q1 2026 came in at $7.7 million, up 6.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $64.9 million (up 1353.66% YoY), and the FY2025 annual result was $35.3 million, up 348.35% from the prior year.
• EBIAT came in at $7.7 million for Q1 2026 at Compugen, down from $56.8 million in the prior quarter.
• In the past five years, EBIAT ranged from a high of $56.8 million in Q4 2025 to a low of -$28.0 million in Q2 2023.
• The 5-year median for EBIAT is $2.1 million (2024), against an average of $3.6 million.
• Peak annual rise in EBIAT reached 1029.3% in 2025, while the deepest fall reached 646.94% in 2025.
• Compugen's EBIAT stood at -$3.1 million in 2022, then surged by 414.13% to $9.7 million in 2023, then plunged by 162.98% to -$6.1 million in 2024, then surged by 1029.3% to $56.8 million in 2025, then slumped by 86.51% to $7.7 million in 2026.
• The last three EBIAT figures came in at $7.7 million (Q1 2026), $56.8 million (Q4 2025), and -$7.0 million (Q3 2025), per Business Quant data.